Trial NCT04068610

View at ClinicalTrials.gov 
Org. Study IDs: D910CC00001
Secondary IDs: 2019-000974-44

Last trial update was posted on 2023-11-15

MeSH Interventions

Bevacizumab Durvalumab

MeSH Conditions

Colorectal Neoplasms

Other Conditions

Metastatic Microsatellite-stable Colorectal Cancer

Stopping Reasons

On 17 February 2022, the decision was made to terminate the clinical study because superior efficacy was not observed for the novel study drug combinations under investigation.

Limitations And Caveats

On 17 February 2022, the decision was made to terminate the clinical study because superior efficacy was not observed for the novel study drug combinations under investigation.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID